DIABETES MELLITUS, TYPE 2
Clinical trials for DIABETES MELLITUS, TYPE 2 explained in plain language.
Never miss a new study
Get alerted when new DIABETES MELLITUS, TYPE 2 trials appear
Sign up with your email to follow new studies for DIABETES MELLITUS, TYPE 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can prescription meals tame diabetes?
Disease control OngoingThis study is testing if delivering healthy, pre-made meals designed for diabetes can help people better manage their blood sugar. It involves 200 adults with type 2 diabetes who also have trouble affording enough food. Half will receive weekly meal deliveries and coaching for 6 …
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Apr 02, 2026 00:57 UTC
-
Can eating breakfast early and morning light fix your body clock and lower blood sugar?
Disease control OngoingThis study is testing if changing *when* you eat and get light exposure can help control type 2 diabetes. Researchers are enrolling 344 adults with type 2 diabetes to try either eating all meals earlier in the day, using timed bright light therapy, both, or neither for 16 weeks. …
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Apr 02, 2026 00:56 UTC
-
DNA-Guided diabetes treatment trial seeks better control
Disease control OngoingThis study is testing whether using patients' genetic information to select diabetes medications works better than standard treatment. Researchers will compare two groups of 504 adults with type 2 diabetes whose blood sugar isn't well controlled. One group will receive medication…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: PHASE4 • Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Disease control
Last updated Apr 02, 2026 00:56 UTC
-
New pill targets triple threat of fatty liver, diabetes, and blood fats
Disease control OngoingThis study is testing whether an oral medication called MN-001 can reduce liver fat and lower triglyceride levels in people who have non-alcoholic fatty liver disease, type 2 diabetes, and high triglycerides. About 40 participants will take either the study drug or a placebo pill…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: PHASE2 • Sponsor: MediciNova • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Can a Low-Carb diet outperform standard advice for diabetes?
Disease control OngoingThis study is testing whether a low-carbohydrate, high-protein diet works better than a standard diabetes diet for managing type 2 diabetes. For 12 months, 100 adults with type 2 diabetes and overweight will follow one of these two diets, with most of their food provided in meal …
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: NA • Sponsor: Bispebjerg Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Weekly injection trial aims to protect vision in diabetes patients
Disease control OngoingThis 5-year study is testing whether adding a weekly injection called semaglutide to standard diabetes care can slow the progression of diabetic eye disease. About 1,500 adults with type 2 diabetes will receive either semaglutide or a placebo injection. Researchers will track cha…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New computer tool aims to help doctors and patients tackle obesity and diabetes together
Disease control OngoingThis study is testing a web-based decision support tool in primary care clinics. The tool provides personalized information to doctors and patients about the potential benefits and risks of different weight loss treatments, like medication or surgery, for people with type 2 diabe…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: NA • Sponsor: HealthPartners Institute • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Heart drug could be secret weapon against diabetes
Disease control TerminatedThis study is testing if a heart failure medication might also help people with type 2 diabetes or pre-diabetes. Researchers want to see if the drug helps the body keep more of a natural hormone that lowers blood sugar after eating. The trial involves 25 adults and compares the e…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: PHASE3 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New sensor could replace finger pricks for millions with diabetes
Disease control OngoingThis study is testing if using a wearable sensor (FreeStyle Libre 3) that continuously tracks blood sugar helps adults with type 2 diabetes manage their condition better than the standard finger-prick method. It involves about 470 adults whose diabetes is not fully controlled des…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: NA • Sponsor: Abbott Diabetes Care • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Can brain games shield seniors with diabetes from memory loss?
Disease control ENROLLING_BY_INVITATIONThis study is testing whether a personalized brain training program on a tablet can help improve thinking skills in older adults with diabetes, who are at higher risk for memory problems. 120 participants aged 60+ will be randomly assigned to use either the active training progra…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: NA • Sponsor: Fanfan Zheng • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Texts and checklists aim to close health gap for Low-Income diabetes patients
Disease control OngoingThis study is testing whether a combination of in-person coaching and text message reminders helps people with type 2 diabetes take their medications more consistently. The goal is to better control blood sugar and reduce the risk of heart disease, especially in low-income and mi…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: NA • Sponsor: Michigan State University • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New tech aims to tame dangerous blood sugar in High-Risk dialysis patients
Disease control OngoingThis study is testing if using a continuous glucose monitor (CGM) can help diabetic patients on kidney dialysis manage their blood sugar better than the standard method of finger-prick checks. It will involve 96 participants who will be assigned to either use a CGM continuously, …
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: NA • Sponsor: Bo Feldt-Rasmussen • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Race to protect babies: finding the right insulin plan for High-Risk pregnancies
Disease control OngoingThis study aims to find the best method to control blood sugar in pregnant women with diabetes who need steroid shots to help their baby's lungs develop early due to risk of preterm birth. Researchers are comparing three different insulin management strategies over 5 days to see …
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Diabetes tech showdown: continuous monitors vs. finger pricks
Disease control OngoingThis study compares two common ways people with type 2 diabetes check their blood sugar: continuous glucose monitors (CGM) worn on the skin versus traditional fingerstick tests. It involves 360 patients across 50 primary care clinics over 12 months to see which method works bette…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: NA • Sponsor: HealthPartners Institute • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Grocery money vs. free delivery: which helps control diabetes better?
Disease control OngoingThis study is testing whether providing monthly money for healthy groceries helps people with type 2 diabetes lower their blood sugar levels more than just offering free grocery delivery. It involves about 1,000 adults with Medi-Cal insurance who have high blood sugar and may str…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: NA • Sponsor: Kaiser Permanente • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Can a natural compound found in food help aging hearts?
Disease control OngoingThis study is testing whether a one-year course of a dietary supplement called spermidine can help older adults with heart disease. Spermidine is a natural compound found in foods like whole grains and nuts. Researchers will check if it improves heart function, muscle mass, physi…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: PHASE2 • Sponsor: University of Aarhus • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Surgery vs. pills: a bold new fight against teen diabetes
Disease control OngoingThis study is testing whether weight-loss surgery is better than intensive medical therapy for long-term blood sugar control in teenagers with type 2 diabetes. It will involve about 90 teens, comparing the effects of a specific surgery (vertical sleeve gastrectomy) against the be…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: PHASE4 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Early test of new shot for weight and diabetes
Disease control OngoingThis early-stage study is testing a new injectable medicine called NNC0519-0130 for people with type 2 diabetes and excess weight. It will measure how the drug moves through the body and check for side effects in 20 Chinese men with overweight or obesity. Participants will receiv…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Wireless watchdog for blood sugar aims to protect hospitalized veterans
Disease control OngoingThis study is testing a new wireless system to monitor blood sugar in hospitalized veterans with type 2 diabetes who are at risk for dangerously low levels. The system sends glucose readings from the patient's bedside directly to the nurses' station, allowing for faster detection…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Remote mentoring trial aims to bridge diabetes care gap for latino communities
Disease control OngoingThis study is testing whether remotely mentoring local clinic teams can help them successfully start a comprehensive diabetes care program. The program includes telehealth support, community health workers, and education specifically for low-income, Spanish-speaking Latino adults…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: NA • Sponsor: The University of Texas Medical Branch, Galveston • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Could a One-Time procedure free diabetics from insulin shots?
Disease control OngoingThis small, early-stage study is testing a new medical procedure for people with type 2 diabetes who require insulin. Doctors use a special device to apply radiofrequency energy to the lining of the first part of the small intestine (the duodenum). The main goal is to see if this…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: NA • Sponsor: Aqua Medical, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
New procedure aims to free diabetes patients from insulin
Disease control OngoingThis study is testing whether a new, minimally invasive endoscopic procedure, which uses electrical pulses to regenerate the lining of the small intestine, can help people with type 2 diabetes who use insulin. When combined with the diabetes medication Ozempic, researchers hope t…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
Massive study checks if diabetes Pill's Life-Saving heart benefits are real for everyone
Disease control OngoingThis study is checking if the heart benefits seen for the diabetes drug empagliflozin in controlled trials also happen for regular patients in real-world doctor's offices and hospitals. It will follow about 230,000 adults with type 2 diabetes who are starting this drug or a simil…
Matched conditions: DIABETES MELLITUS, TYPE 2
Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Can fellow patients help black men beat diabetes?
Disease control OngoingThis study is testing whether adding peer support helps Black men better manage type 2 diabetes. All 48 participants receive standard diabetes education. Half also get 6 months of monthly support sessions led by trained Black men who also have diabetes, followed by 6 months of gr…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: NA • Sponsor: University of Michigan • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New drug combo tested to fight fatty liver in diabetics
Disease control ENROLLING_BY_INVITATIONThis study aims to see if a combination diabetes drug (iGlarLixi) works better than standard insulin (iGlar) at reducing fat in the liver. It will involve 36 adults who have both type 2 diabetes and a fatty liver condition called MASLD. Participants will take one of the two treat…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: PHASE4 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
Second chance for failed diabetes treatment?
Disease control OngoingThis study is testing a second, similar procedure for people with type 2 diabetes whose blood sugar did not improve enough after an initial experimental treatment. The procedure uses heat to treat the lining of the small intestine. Researchers want to see if this repeat treatment…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: NA • Sponsor: Aqua Medical, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:28 UTC
-
New weekly shot aims to help shed pounds and control diabetes
Disease control OngoingThis study is testing whether a weekly injectable medicine called survodutide helps adults with type 2 diabetes and overweight or obesity lose weight. About 755 participants will be randomly assigned to receive one of two doses of the drug or a placebo (a dummy injection) for 76 …
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Mar 23, 2026 15:20 UTC
-
New diabetes drug combo challenges leading treatment in major Head-to-Head trial
Disease control OngoingThis study is testing whether a new weekly injection called CagriSema works better than an existing drug called tirzepatide for controlling type 2 diabetes. About 1,023 adults whose diabetes isn't well-controlled on common pills will be randomly assigned to receive one of these t…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Diabetes drug duo trial halted before starting
Disease control TerminatedThis study aimed to test if using two diabetes drugs together works better than using either one alone for people whose blood sugar is still too high on metformin. It planned to enroll adults with type 2 diabetes to compare the combination's effectiveness and safety over 16 weeks…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Massive 15,000-Person diabetes drug study launches
Disease control OngoingThis study aims to see how well two diabetes medications, Envlo and Envlomet SR, control blood sugar in real-world medical practice. It will observe 15,000 adults with type 2 diabetes for 24 weeks to measure changes in their blood sugar levels and check for safety. Unlike a contr…
Matched conditions: DIABETES MELLITUS, TYPE 2
Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Trial for new diabetes duo withdrawn before starting
Disease control TerminatedThis study aimed to see if adding a new drug called ofirnoflast to the existing medication semaglutide (like Ozempic®) was better for blood sugar control and weight loss in adults with type 2 diabetes who were overweight or obese. It was designed as a 12-week trial comparing the …
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: PHASE2 • Sponsor: Halia Therapeutics, Inc. • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC
-
Can diet beat pills for fixing a fatty liver?
Disease control ENROLLING_BY_INVITATIONThis study aims to see if a specific eating plan is better than a prescription medication for reducing liver fat and scarring. Researchers will compare a Mediterranean diet combined with intermittent fasting against the weight-loss drug naltrexone/bupropion (Mysimba®). The goal i…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: PHASE4 • Sponsor: Carmen Dietvorst • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC
-
Family teamwork tested to fight diabetes
Disease control OngoingThis study tests whether a family-focused coaching program helps African American adults better manage their type 2 diabetes. Participants and a family member attend virtual group sessions about diabetes care and support over 12 weeks. Researchers measure changes in blood sugar c…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: PHASE1, PHASE2 • Sponsor: Ohio State University • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC
-
New study: simple relaxation and sleep tips may tame blood sugar
Disease control ENROLLING_BY_INVITATIONThis study is testing whether teaching people with Type 2 diabetes about good sleep habits and leading them through relaxation exercises can help them sleep better, feel less anxious, and improve their blood sugar control. Researchers will work with 52 adults who have poor sleep …
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: NA • Sponsor: Gazi University • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC
-
Can the right diet and exercise combo curb cravings and control diabetes?
Disease control OngoingThis study is testing how a 12-week program of diet education and different types of exercise affects people with type 2 diabetes and obesity. Researchers want to see if these lifestyle changes can help control appetite, improve body composition, and better manage blood sugar. Th…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: NA • Sponsor: University of Cadiz • Aim: Disease control
Last updated Feb 24, 2026 14:06 UTC
-
Can a cultural twist on healthy eating help fight diabetes?
Prevention OngoingThis study is testing whether making national healthy eating guidelines more culturally relevant helps African American adults improve their diets and lower their risk for type 2 diabetes. Researchers are comparing three different healthy eating patterns over one year to see whic…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: NA • Sponsor: University of South Carolina • Aim: Prevention
Last updated Apr 01, 2026 14:42 UTC
-
Digital tool aims to stop diabetes in new moms
Prevention ENROLLING_BY_INVITATIONThis study is testing an online program designed to help women who had diabetes during pregnancy (gestational diabetes) get the recommended follow-up diabetes screening and join lifestyle programs after giving birth. The goal is to prevent these women from developing type 2 diabe…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: NA • Sponsor: University of California, Davis • Aim: Prevention
Last updated Mar 27, 2026 12:38 UTC
-
New combo drug trial targets debilitating diabetic nerve pain
Symptom relief OngoingThis study is testing whether weekly injections of an investigational drug called CagriSema can reduce pain from diabetic nerve damage. It will compare CagriSema to a placebo in 142 adults with type 2 diabetes who have had this specific nerve pain for at least 3 months. The main …
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Symptom relief
Last updated Apr 02, 2026 00:57 UTC
-
Diabetes patients rate their new injection device
Symptom relief OngoingThis study is collecting feedback from people already using the DuraTouch insulin injection device in their daily lives. About 125 people with type 1 or type 2 diabetes will rate how easy, convenient, and satisfying the device is to use over 12 weeks. The goal is to understand th…
Matched conditions: DIABETES MELLITUS, TYPE 2
Sponsor: Novo Nordisk A/S • Aim: Symptom relief
Last updated Mar 24, 2026 12:06 UTC
-
Scientists build a 'Library' of body samples to unlock Obesity's secrets
Knowledge-focused OngoingThis study aims to collect and store blood, urine, and tissue samples from 500 adults with obesity. The goal is to create a research bank to help scientists understand why people gain weight, why treatments sometimes fail, and why weight is often regained. This knowledge could le…
Matched conditions: DIABETES MELLITUS, TYPE 2
Sponsor: Pichamol Jirapinyo, MD, MPH • Aim: Knowledge-focused
Last updated Apr 02, 2026 00:56 UTC
-
Scientists test best workout and diet combo for diabetes
Knowledge-focused OngoingThis study aims to understand how different types of exercise and dietary advice affect the body's cells and stress levels in people with type 2 diabetes. Researchers enrolled 146 participants to compare moderate exercise, high-intensity intervals, and diet counseling over 12 wee…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: NA • Sponsor: University of Cadiz • Aim: Knowledge-focused
Last updated Apr 02, 2026 00:56 UTC
-
Diabetes drug tested as potential shield against Post-Cataract cloudiness
Knowledge-focused OngoingThis study aims to understand if the common diabetes medication metformin reaches the eye's lens and can slow the growth of cells that cause cloudy vision after cataract surgery. Researchers will collect lens tissue and blood samples from 40 patients with type 2 diabetes and cata…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: NA • Sponsor: Vienna Institute for Research in Ocular Surgery • Aim: Knowledge-focused
Last updated Apr 02, 2026 00:56 UTC
-
Researchers track Decades-Long impact of diabetes on native american kidneys
Knowledge-focused TerminatedThis study follows American Indians with type 2 diabetes to understand the long-term effects of a previous kidney treatment trial. Researchers are observing how kidney disease progresses over many years through regular tests, scans, and optional biopsies. No new treatment is prov…
Matched conditions: DIABETES MELLITUS, TYPE 2
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Apr 02, 2026 00:56 UTC
-
Massive french study tracks Real-World health of half a million diabetes patients
Knowledge-focused OngoingThis study aims to understand how SGLT2i diabetes drugs are prescribed and used in France by analyzing health records. It will track over 500,000 patients starting this treatment to see if it is linked to real-world health outcomes like heart attacks, strokes, heart failure, and …
Matched conditions: DIABETES MELLITUS, TYPE 2
Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:10 UTC
-
Scientists test two Phone-Based health trackers for diabetes
Knowledge-focused OngoingThis study is testing which of two remote health monitoring setups is more practical and acceptable for people with type 2 diabetes. It involves 60 adults in Denmark who will use smartphones and devices to track their health from home for three months. The goal is to gather infor…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: NA • Sponsor: Aalborg University Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
Could vitamin d levels hold a key to blood pressure in diabetes?
Knowledge-focused OngoingThis study aims to understand how vitamin D levels might influence high blood pressure in people with type 2 diabetes. Researchers will take blood samples from 40 participants to examine a specific type of white blood cell. They want to see if these cells from people with low vit…
Matched conditions: DIABETES MELLITUS, TYPE 2
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC
-
Scientists hunt for hidden clues in mexican diabetes patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to understand why some people with type 2 diabetes have a harder time controlling their blood sugar and develop kidney problems. Researchers will collect health information, lifestyle details, and blood samples from 1000 adults with diabetes in Mexico. By analyzin…
Matched conditions: DIABETES MELLITUS, TYPE 2
Sponsor: Coordinación de Investigación en Salud, Mexico • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC
-
Massive 20-Year study tracks hidden heart disease in thousands
Knowledge-focused OngoingThis is a long-term observational study that aims to understand how heart and blood vessel diseases develop in people before they show symptoms. It follows over 6,400 healthy men and women from four different ethnic backgrounds, aged 45-84, using regular scans and tests over many…
Matched conditions: DIABETES MELLITUS, TYPE 2
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC
-
French health data reveals: does heart screening actually help diabetes patients?
Knowledge-focused OngoingThis study uses French national health insurance data to see if routinely screening for hidden heart disease helps prevent major heart problems in people with type 2 diabetes who are at very high risk. It will compare the health outcomes and costs for about 90,000 patients who we…
Matched conditions: DIABETES MELLITUS, TYPE 2
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:09 UTC
-
Scientists hunt for genetic clues to personalize diabetes treatment
Knowledge-focused OngoingThis study aims to understand if a person's genes can predict how they will respond to a common diabetes drug called canagliflozin. Researchers are giving the drug to 700 healthy Amish volunteers and measuring its effects on the body. They will then look for genetic patterns link…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: PHASE1 • Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:19 UTC
-
Diabetes patients tested: does daily aspirin actually work?
Knowledge-focused OngoingThis early study aims to understand how well daily low-dose aspirin prevents blood clotting in people with type 2 diabetes. Researchers will give 50 participants aspirin for 7 days and measure their blood's clotting response before and after treatment. The goal is to gather preli…
Matched conditions: DIABETES MELLITUS, TYPE 2
Phase: EARLY_PHASE1 • Sponsor: Montreal Heart Institute • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:47 UTC
-
Scientists hunt for diabetes genes in major study
Knowledge-focused TerminatedThis study aims to discover the specific genes and biological pathways that influence a person's risk of developing type 2 diabetes and related health problems like kidney and eye disease. Researchers will collect health information, blood samples, and genetic data from over 2,00…
Matched conditions: DIABETES MELLITUS, TYPE 2
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:25 UTC